Agency Forms Undergoing Paperwork Reduction Act Review, 30682-30683 [2015-12996]

Download as PDF 30682 Federal Register / Vol. 80, No. 103 / Friday, May 29, 2015 / Notices government risk assessments. Selection of contractors about which information may be collected during the assessment process will be a risk-based decision made at the discretion of a participating agency. Definition: Information system in this notice means a discrete set of information resources organized expressly for the collection, processing, maintenance, use, sharing, dissemination, or disposition of information. Information systems also include specialized systems such as industrial or process controls systems, telephone switching or private branch exchange (PBX) systems, and environmental control systems (see, National Institute of Standards and Technology Special Publication 800–53 Rev. 4). Links to relevant documents can be found at: Business Due Diligence RFI: https://www.fbo.gov/ index?s=opportunity&mode =form&id=230732591f542b7da 9b9fc3e6c167eec&tab=core&_cview=0; Executive Order 13636, Improving Critical Infrastructure Cybersecurity: https://www.gsa.gov/portal/content/ 176547. Dated: May 21, 2015. Giancarlo Brizzi, Acting Associate Administrator, Office of Government-wide Policy, General Services Administration. Proposed Project Integrating Community Pharmacists and Clinical Sites for Patient-Centered HIV Care (OMB No. 0920–1019, Expires 05/31/2017)—[Revision]—National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC). [FR Doc. 2015–13016 Filed 5–28–15; 8:45 am] BILLING CODE 6820–14–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Background and Brief Description Centers for Disease Control and Prevention [30Day–15–1019] Lhorne on DSK2VPTVN1PROD with NOTICES Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of VerDate Sep<11>2014 15:17 May 28, 2015 Jkt 235001 the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Written comments and/or suggestions regarding the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Revisions to this information collection include the addition of an Interviewer data collection worksheet, Key Informant Interviewer script, Staff communication questionnaire, Clinic cost form and Pharmacy cost form. These additions are needed in order to determine changes to clinic and pharmacy work systems, processes and outcomes in relation to the model project and how and if the model program improves patient outcomes through improved communication and collaboration between patients’ clinical providers and pharmacists. In order to determine the general feasibility of the model program, the time required conducting program activities and the associated cost of program activities must be determined. Collection of data from the previously approved Initial patient information forms, Quarterly patient information forms, Pharmacy record abstraction forms, Project clinic PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 characteristics forms, and Project pharmacy characteristics forms is ongoing. Clinic staff will use the initial information Sheet to explain the project to patients. CDC has entered into a partnership with Walgreen Company (a.k.a. Walgreens pharmacies, a national retail pharmacy chain) and the University of North Texas Health Science Center to develop and implement a model of HIV care that integrates community pharmacists with primary medical providers for patient-centered HIV care. The model program will be implemented at ten sites and will provide patient-centered HIV care for approximately 1,000 persons. The patient-centered HIV care model includes the core elements of pharmacist provided Medication Therapy Management (MTM) as well as additional pharmacist services such as individualized medication adherence counseling, active monitoring of prescription refills and active collaboration between pharmacists and medical clinic providers to identify and resolve medication related treatment problems such as treatment effectiveness, adverse events and poor adherence. The expected outcomes of the model program are increased retention in HIV care, adherence to HIV medication therapy and HIV viral load suppression. Pharmacy, laboratory and medical data are collected through abstraction of participant clients’ pharmacy and medical records. These data are needed to monitor retention in care, adherence to therapy, viral load suppression and other health outcomes. Program specific data, such as the number of MTM elements completed per project site and project sites’ characteristics, will be collected by project sites. This information collection will allow CDC to conduct continuous program performance monitoring which includes identification of barriers to program implementation, solutions to those barriers, and documentation of client health outcomes. Performance monitoring will allow the model program to be adjusted, as needed, in order to develop a final implementation model that is self-sustaining and which can be used to establish similar collaborations in a variety of clinical settings. Collection of cost data will allow for the cost of the program to be estimated. There is no cost to participants other than their time. The total estimated annualized burden hours are 6,043. E:\FR\FM\29MYN1.SGM 29MYN1 30683 Federal Register / Vol. 80, No. 103 / Friday, May 29, 2015 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondent Form name Clinic Data Manager ....................................... Pharmacist ...................................................... Clinic Data Manager ....................................... Clinic Data Manager ....................................... Clinic Data Manager ....................................... Pharmacist ...................................................... Key informants ................................................ Project pharmacists and clinic staff ................ Clinic staff ....................................................... Pharmacy staff ................................................ Project clinic characteristics form .................. Project pharmacy characteristics form ........... Patient Demographic Information form .......... Initial patient information form ........................ Quarterly patient information form ................. Pharmacy record abstraction form ................. Interviewer data collection worksheet ............ Staff communication questionnaire ................ Clinic cost form .............................................. Pharmacy cost form ....................................... Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2015–12996 Filed 5–28–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10102] Agency Information Collection Activities: Submission for OMB Review; Comment Request ACTION: Notice. The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Lhorne on DSK2VPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 15:17 May 28, 2015 Jkt 235001 Comments on the collection(s) of information must be received by the OMB desk officer by June 29, 2015. ADDRESSES: When commenting on the proposed information collections, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be received by the OMB desk officer via one of the following transmissions: OMB, Office of Information and Regulatory Affairs, Attention: CMS Desk Officer, Fax Number: (202) 395–5806 OR, Email: OIRA_submission@omb.eop.gov . To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, you may make your request using one of following: 1. Access CMS’ Web site address at https://www.cms.hhs.gov/ PaperworkReductionActof1995. 2. Email your request, including your address, phone number, OMB number, and CMS document identifier, to Paperwork@cms.hhs.gov. 3. Call the Reports Clearance Office at (410) 786–1326. FOR FURTHER INFORMATION CONTACT: Reports Clearance Office at (410) 786– 1326. DATES: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires federal agencies to publish a 30-day notice in the Federal Register concerning each proposed collection of information, SUPPLEMENTARY INFORMATION: PO 00000 Frm 00033 Fmt 4703 Sfmt 9990 Number of responses per respondent 10 10 10 10 10 10 60 70 20 20 Average burden per response (in hours) 3 3 100 100 400 400 2 2 2 2 30/60 30/60 5/60 1 30/60 30/60 30/60 15/60 10 10 including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice that summarizes the following proposed collection(s) of information for public comment: 1. Type of Information Collection Request: Extension of a currently approved collection; Title of Information Collection: National Implementation of the Hospital CAHPS Survey; Use: The HCAHPS (Hospital Consumer Assessment of Healthcare Providers and Systems) Survey, also known as the CAHPS® Hospital Survey or Hospital CAHPS®, is a standardized survey instrument and data collection methodology that has been in use since 2006 to measure patients’ perspectives of hospital care. While many hospitals collect information on patient satisfaction, HCAHPS created a national standard for collecting and public reporting information that enables valid comparisons to be made across all hospitals to support consumer choice. Form Number: CMS–10102 (OMB control number 0938–0981); Frequency: Occasionally; Affected Public: Private sector (Business or other for-profits and Not-for-profit institutions); Number of Respondents: 4,200; Total Annual Responses: 3,100,000; Total Annual Hours: 413,230. (For policy questions regarding this collection contact William Lehrman at 410–786–1037.) Dated: May 23, 2015. William N. Parham, III, Director, Paperwork Reduction Staff, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2015–12993 Filed 5–28–15; 8:45 am] BILLING CODE 4120–01–P E:\FR\FM\29MYN1.SGM 29MYN1

Agencies

[Federal Register Volume 80, Number 103 (Friday, May 29, 2015)]
[Notices]
[Pages 30682-30683]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-12996]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-15-1019]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    Integrating Community Pharmacists and Clinical Sites for Patient-
Centered HIV Care (OMB No. 0920-1019, Expires 05/31/2017)--[Revision]--
National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    Revisions to this information collection include the addition of an 
Interviewer data collection worksheet, Key Informant Interviewer 
script, Staff communication questionnaire, Clinic cost form and 
Pharmacy cost form. These additions are needed in order to determine 
changes to clinic and pharmacy work systems, processes and outcomes in 
relation to the model project and how and if the model program improves 
patient outcomes through improved communication and collaboration 
between patients' clinical providers and pharmacists. In order to 
determine the general feasibility of the model program, the time 
required conducting program activities and the associated cost of 
program activities must be determined. Collection of data from the 
previously approved Initial patient information forms, Quarterly 
patient information forms, Pharmacy record abstraction forms, Project 
clinic characteristics forms, and Project pharmacy characteristics 
forms is ongoing. Clinic staff will use the initial information Sheet 
to explain the project to patients.
    CDC has entered into a partnership with Walgreen Company (a.k.a. 
Walgreens pharmacies, a national retail pharmacy chain) and the 
University of North Texas Health Science Center to develop and 
implement a model of HIV care that integrates community pharmacists 
with primary medical providers for patient-centered HIV care. The model 
program will be implemented at ten sites and will provide patient-
centered HIV care for approximately 1,000 persons.
    The patient-centered HIV care model includes the core elements of 
pharmacist provided Medication Therapy Management (MTM) as well as 
additional pharmacist services such as individualized medication 
adherence counseling, active monitoring of prescription refills and 
active collaboration between pharmacists and medical clinic providers 
to identify and resolve medication related treatment problems such as 
treatment effectiveness, adverse events and poor adherence. The 
expected outcomes of the model program are increased retention in HIV 
care, adherence to HIV medication therapy and HIV viral load 
suppression.
    Pharmacy, laboratory and medical data are collected through 
abstraction of participant clients' pharmacy and medical records. These 
data are needed to monitor retention in care, adherence to therapy, 
viral load suppression and other health outcomes. Program specific 
data, such as the number of MTM elements completed per project site and 
project sites' characteristics, will be collected by project sites.
    This information collection will allow CDC to conduct continuous 
program performance monitoring which includes identification of 
barriers to program implementation, solutions to those barriers, and 
documentation of client health outcomes. Performance monitoring will 
allow the model program to be adjusted, as needed, in order to develop 
a final implementation model that is self-sustaining and which can be 
used to establish similar collaborations in a variety of clinical 
settings. Collection of cost data will allow for the cost of the 
program to be estimated. There is no cost to participants other than 
their time. The total estimated annualized burden hours are 6,043.

[[Page 30683]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondent                    Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Clinic Data Manager...................  Project clinic                        10               3           30/60
                                         characteristics form.
Pharmacist............................  Project pharmacy                      10               3           30/60
                                         characteristics form.
Clinic Data Manager...................  Patient Demographic                   10             100            5/60
                                         Information form.
Clinic Data Manager...................  Initial patient                       10             100               1
                                         information form.
Clinic Data Manager...................  Quarterly patient                     10             400           30/60
                                         information form.
Pharmacist............................  Pharmacy record                       10             400           30/60
                                         abstraction form.
Key informants........................  Interviewer data                      60               2           30/60
                                         collection worksheet.
Project pharmacists and clinic staff..  Staff communication                   70               2           15/60
                                         questionnaire.
Clinic staff..........................  Clinic cost form........              20               2              10
Pharmacy staff........................  Pharmacy cost form......              20               2              10
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-12996 Filed 5-28-15; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.